Vaxart Stock Slides 2% as Board Aligns Ownership, Eyes Oral Flu Vaccine Milestones
Vaxart’s stock dips 2% as board ownership tightens; oral flu vaccine tech could spark future upside, so watch clinical milestones for a rally.
2 minutes to read
VAXART INC
Vaxart Boosts Growth with Vice Admiral Bono on Board, Eyes Oral Flu Vaccine Breakthrough
Vaxart strengthens governance with former Navy Vice Admiral on board, aiming to accelerate its oral flu vaccine launch and unlock new growth amid modest price shifts.
3 minutes to read
Vaxart Adds Former Vice Admiral to Board, Aiming to Accelerate Oral Flu Vaccine Success
Vaxart’s board gains former Vice Admiral Raquel C. Bono, boosting governance and clinical strategy for its oral vaccine platform and potential upside.
3 minutes to read